Treatment of patients with aortic atherosclerotic disease with paclitaxel-associated lipid nanoparticles

医学 紫杉醇 病变 体表面积 胃肠病学 内科学 癌症 心脏病学 放射科 病理 泌尿科
作者
Afonso Akio Shiozaki,Tiago Senra,Aleksandra T. Morikawa,Débora F. Deus,Antonio Tito Paladino,Ibraim Pinto,Raul C. Maranhão
出处
期刊:Clinics [Elsevier BV]
卷期号:71 (8): 435-439 被引量:49
标识
DOI:10.6061/clinics/2016(08)05
摘要

OBJECTIVE:The toxicity of anti-cancer chemotherapeutic agents can be reduced by associating these compounds, such as the anti-proliferative agent paclitaxel, with a cholesterol-rich nanoemulsion (LDE) that mimics the lipid composition of low-density lipoprotein (LDL).When injected into circulation, the LDE concentrates the carried drugs in neoplastic tissues and atherosclerotic lesions.In rabbits, atherosclerotic lesion size was reduced by 65% following LDE-paclitaxel treatment.The current study aimed to test the effectiveness of LDE-paclitaxel on inpatients with aortic atherosclerosis.METHODS: This study tested a 175 mg/m 2 body surface area dose of LDE-paclitaxel (intravenous administration, 3/3 weeks for 6 cycles) in patients with aortic atherosclerosis who were aged between 69 and 86 yrs.A control group of 9 untreated patients with aortic atherosclerosis (72-83 yrs) was also observed. RESULTS:The LDE-paclitaxel treatment elicited no important clinical or laboratory toxicities.Images were acquired via multiple detector computer tomography angiography (64-slice scanner) before treatment and at 1-2 months after treatment.The images showed that the mean plaque volume in the aortic artery wall was reduced in 4 of the 8 patients, while in 3 patients it remained unchanged and in one patient it increased.In the control group, images were acquired twice with an interval of 6-8 months.None of the patients in this group exhibited a reduction in plaque volume; in contrast, the plaque volume increased in three patients and remained stable in four patients.During the study period, one death unrelated to the treatment occurred in the LDE-paclitaxel group and one death occurred in the control group.CONCLUSION: Treatment with LDE-paclitaxel was tolerated by patients with cardiovascular disease and showed the potential to reduce atherosclerotic lesion size.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
Singularity发布了新的文献求助20
4秒前
chenchen完成签到 ,获得积分10
5秒前
7秒前
含糊的盼波完成签到,获得积分10
8秒前
光亮如容完成签到,获得积分10
12秒前
12秒前
浩浩完成签到 ,获得积分0
15秒前
圆圆完成签到 ,获得积分10
27秒前
chunlily完成签到 ,获得积分10
27秒前
xujiahao完成签到,获得积分10
28秒前
29秒前
黑米粥发布了新的文献求助200
34秒前
34秒前
zw完成签到,获得积分10
35秒前
沉默岩完成签到,获得积分10
39秒前
中恐完成签到,获得积分0
39秒前
JamesPei的应助被shally采纳,获得10
40秒前
肥猫完成签到,获得积分10
44秒前
谦让的忆枫完成签到,获得积分10
44秒前
lll完成签到 ,获得积分10
45秒前
黑米粥发布了新的文献求助200
47秒前
arniu2008的应助被科研通管家采纳,获得20
49秒前
arniu2008的应助被科研通管家采纳,获得20
49秒前
arniu2008的应助被科研通管家采纳,获得20
49秒前
49秒前
开心完成签到 ,获得积分10
52秒前
shally发布了新的文献求助10
56秒前
Zzy完成签到 ,获得积分10
57秒前
沙漏的回忆完成签到 ,获得积分10
58秒前
zhao完成签到,获得积分10
1分钟前
1分钟前
starlx0813发布了新的文献求助50
1分钟前
黑米粥发布了新的文献求助200
1分钟前
Meera完成签到,获得积分10
1分钟前
拼搏忆文完成签到,获得积分10
1分钟前
慕青的应助被我要睡觉w采纳,获得10
1分钟前
科研顺利完成签到,获得积分10
1分钟前
深情安青的应助被dejavu采纳,获得10
1分钟前
qiancib202完成签到,获得积分0
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8185502
求助须知:如何正确求助?哪些是违规求助? 9574220
关于积分的说明 21834553
捐赠科研通 7783121
什么是DOI,文献DOI怎么找? 3434577
关于科研通互助平台的介绍 2558949
邀请新用户注册赠送积分活动 2481357